Relationship between interleukin-6 levels in gingival crevicular fluid and periodontal status in patients with rheumatoid arthritis and adult periodontitis

被引:55
作者
Bozkurt, FY
Berker, E
Akkus, S
Bulut, S
机构
[1] Suleyman Demirel Univ, Fac Dent, Dept Periodontol, TR-32100 Isparta, Turkey
[2] Univ Hacettepe, Fac Dent, Dept Periodontol, TR-06100 Ankara, Turkey
[3] Univ Suleyman Demirel, Fac Med, Dept Rheumatol, Isparta, Turkey
[4] Baskent Univ, Fac Dent, Dept Periodontol, TR-06490 Ankara, Turkey
关键词
gingival crevicular fluid/analysis; cytokines; interleukin-6; arthritis; rheumatoid/physiopathology; periodontitis/physiopathology;
D O I
10.1902/jop.2000.71.11.1756
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background: The aim of this study was to determine and compare interleukin-6 (IL-6) levels in gingival crevicular fluid (GCF) and clinical periodontal findings in patients with rheumatoid arthritis (RA) and adult periodontitis (AP). Methods: A total of 45 patients divided into 3 groups (15 patients with RA and AP, 15 patients with AP, and 15 periodontally healthy subjects) were included in this study. Plaque index (PI), gingival index (GI), sulcus bleeding index (SBI), probing depth (PD), and attachment level (AL) values for each patient were recorded. Enzyme-linked immunosorbent assay for quantitative detection of IL-6 in each GCF sample was employed. Results: No significant difference could be detected between the RA and AP groups in the mean clinical parameter data except PI. Although the mean GCF IL-6 level in the RA group was the highest, no significant difference could be found among the groups. There was only a strong negative correlation between GCF IL-6 levels and GI scores in the RA group. Conclusions: In the patients with RA, despite increased local tissue destruction potential due to autoimmunity and higher PI levels than in the AP patients, our findings suggest that medication including corticosteroid and non-steroidal anti-inflammatory drugs may decrease gingival inflammation, but the synthesis and degradation of IL-6 in gingival tissue of RA patients may be different. To our knowledge, this study is the first report determining GCF IL-6 levels in RA patients.
引用
收藏
页码:1756 / 1760
页数:5
相关论文
共 45 条
[1]   Crevicular fluid interleukin-1β, tumor necrosis factor-α, and interleukin-6 levels in renal transplant patients receiving cyclosporine A [J].
Atilla, G ;
Kütükçüler, N .
JOURNAL OF PERIODONTOLOGY, 1998, 69 (07) :784-790
[2]   INTERRELATIONSHIPS BETWEEN INTERLEUKIN (IL)-1, IL-6 AND IL-8 IN SYNOVIAL-FLUID OF VARIOUS ARTHROPATHIES [J].
BERTAZZOLO, N ;
PUNZI, L ;
STEFANI, MP ;
CESARO, G ;
PIANON, M ;
FINCO, B ;
TODESCO, S .
AGENTS AND ACTIONS, 1994, 41 (1-2) :90-92
[3]  
CAMPBELL IL, 1989, J IMMUNOL, V143, P1188
[4]   Prostaglandin E(2) potentiates interleukin-1 beta induced interleukin-6 production by human gingival fibroblasts [J].
Czuszak, CA ;
Sutherland, DE ;
Billman, MA ;
Stein, SH .
JOURNAL OF CLINICAL PERIODONTOLOGY, 1996, 23 (07) :635-640
[5]   The influence of indomethacin on the metabolism and cytokine secretion of human aneurysmal aorta [J].
Franklin, IJ ;
Walton, IJ ;
Greenhalgh, RM ;
Powell, JT .
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 1999, 18 (01) :35-42
[6]   PATHOPHYSIOLOGY OF CYTOKINES [J].
FRIDMAN, WH ;
MICHON, J .
LEUKEMIA RESEARCH, 1990, 14 (08) :675-677
[7]   MEASUREMENTS OF INTERLEUKIN-6 IN GINGIVAL CREVICULAR FLUID FROM ADULTS WITH DESTRUCTIVE PERIODONTAL-DISEASE [J].
GEIVELIS, M ;
TURNER, DW ;
PEDERSON, ED ;
LAMBERTS, BL .
JOURNAL OF PERIODONTOLOGY, 1993, 64 (10) :980-983
[8]   INTERLEUKIN-1, INTERLEUKIN-6 AND TRANSFORMING GROWTH-FACTOR-BETA PRODUCTION BY HUMAN GINGIVAL MONONUCLEAR-CELLS FOLLOWING STIMULATION WITH PORPHYROMONAS-GINGIVALIS AND FUSOBACTERIUM-NUCLEATUM [J].
GEMMELL, E ;
SEYMOUR, GJ .
JOURNAL OF PERIODONTAL RESEARCH, 1993, 28 (02) :122-129
[9]   HOST RESPONSES IN PERIODONTAL-DISEASES - CURRENT CONCEPTS [J].
GENCO, RJ .
JOURNAL OF PERIODONTOLOGY, 1992, 63 (04) :338-355
[10]   HOST RESPONSES IN PERIODONTAL-DISEASES [J].
GENCO, RJ ;
SLOTS, J .
JOURNAL OF DENTAL RESEARCH, 1984, 63 (03) :441-451